Yes, we currently have GHRP-6 (5mg x 10), Ipamorelin (5mg x 10) in stock
Power calculations suggest that previous studies would have had limited power to detect an effect size similar to that identified in our study (Supplementary Table 23), and also differed in terms of drug type, disease cohort and analytical choices
Currently, GLP1 receptor agonists are not approved to treat depression
The overall appearance of our skin, hair and our nails reflects our general health in so many ways and is very much linked to our daily nutrition, which is responsible for their continual nourishment and growth
Domestic Cold-Chain for Both Compounds Temperature-sensitive GH axis peptides degrade under improper shipping conditions
New Safety Signal: Dysesthesia TRIUMPH-4 did reveal a new side effect not seen in Phase 2 trials: dysesthesia, which presents as unusual skin sensitivity, tingling, or tenderness to the touch